Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Warrant dilution ending? 18 miilion left?
That's what it looks like. IMO, all things considered, a decent 10Q. As others have expressed, annualized EPS @ 10 cents/share with a current multiple of 10 should put us at a buck, but with the Markman so close I doubt we will see a buck until the outcome is known. If we prevail at the Markman and the defendants settle, than IMO the multiple increases as well and we should see even more growth in the PPS. Everything IMO hinges on May 3rd. AMVHO Hang in there everyone. GLTAL
Share
New Message
Please login to post a reply